SG Americas Securities »

Verve Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $708k 51k 13.94
2023-09-30 $248k 19k 13.25
2022-12-31 $297k 15k 19.35
2022-09-30 $269k 7.8k 34.39
2021-09-30 $330k 7.0k 47.04